Andreas Langer

2.0k total citations
39 papers, 1.4k citations indexed

About

Andreas Langer is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Biomedical Engineering. According to data from OpenAlex, Andreas Langer has authored 39 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 7 papers in Biomedical Engineering. Recurrent topics in Andreas Langer's work include Renin-Angiotensin System Studies (5 papers), Microfluidic and Capillary Electrophoresis Applications (5 papers) and Molecular Junctions and Nanostructures (4 papers). Andreas Langer is often cited by papers focused on Renin-Angiotensin System Studies (5 papers), Microfluidic and Capillary Electrophoresis Applications (5 papers) and Molecular Junctions and Nanostructures (4 papers). Andreas Langer collaborates with scholars based in Germany, Switzerland and Egypt. Andreas Langer's co-authors include Ursula Quitterer, Said AbdAlla, Ulrike Müller, Yasser el Faramawy, Heinz Lother, Edmond Dupont, Colette Bouillot, Bernadette Allinquant, Isabelle Caillé and Alain Prochiantz and has published in prestigious journals such as Cell, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Andreas Langer

37 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Langer Germany 17 718 497 261 184 135 39 1.4k
Uliano Guerrini Italy 29 1.1k 1.5× 453 0.9× 286 1.1× 368 2.0× 101 0.7× 63 2.5k
Ming Zou China 21 848 1.2× 378 0.8× 233 0.9× 76 0.4× 106 0.8× 65 1.8k
Lakshmanan K. Iyer United States 24 1.1k 1.5× 235 0.5× 280 1.1× 91 0.5× 54 0.4× 50 2.4k
Toshiyuki Sato Japan 21 550 0.8× 197 0.4× 126 0.5× 60 0.3× 64 0.5× 103 1.5k
Mariano A. Ostuni France 19 784 1.1× 367 0.7× 167 0.6× 40 0.2× 50 0.4× 63 1.6k
R. F. G. Booth United Kingdom 19 817 1.1× 376 0.8× 456 1.7× 228 1.2× 54 0.4× 38 2.0k
Mark Fidock United Kingdom 20 807 1.1× 323 0.6× 329 1.3× 129 0.7× 97 0.7× 32 1.6k
Yuxia Luo China 13 1.1k 1.6× 645 1.3× 260 1.0× 95 0.5× 209 1.5× 34 1.9k
Heather H. Shih United States 18 931 1.3× 414 0.8× 232 0.9× 42 0.2× 76 0.6× 24 1.7k
Hirokazu Tsujimoto Japan 15 984 1.4× 181 0.4× 410 1.6× 269 1.5× 48 0.4× 22 1.5k

Countries citing papers authored by Andreas Langer

Since Specialization
Citations

This map shows the geographic impact of Andreas Langer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Langer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Langer more than expected).

Fields of papers citing papers by Andreas Langer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Langer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Langer. The network helps show where Andreas Langer may publish in the future.

Co-authorship network of co-authors of Andreas Langer

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Langer. A scholar is included among the top collaborators of Andreas Langer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Langer. Andreas Langer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Langer, Andreas, et al.. (2024). Intraoperative pelvic neuromonitoring based on bioimpedance signals: a new method analyzed on 30 patients. Langenbeck s Archives of Surgery. 409(1). 237–237. 1 indexed citations
3.
Langer, Andreas, et al.. (2023). Technical aspects of a new approach to intraoperative pelvic neuromonitoring during robotic rectal surgery. Scientific Reports. 13(1). 3 indexed citations
4.
Langer, Andreas, et al.. (2023). Identification of membrane palmitoylated protein 1 (MPP1) as a heart-failure-promoting protein triggered by cardiovascular risk factors and aging. Biochemical Pharmacology. 217. 115789–115789. 2 indexed citations
5.
Langer, Andreas, et al.. (2022). A New Spectral Shift-Based Method to Characterize Molecular Interactions. Assay and Drug Development Technologies. 20(2). 83–94. 33 indexed citations
6.
Langer, Andreas, et al.. (2022). A new method of intraoperative pelvic neuromonitoring: a preclinical feasibility study in a porcine model. Scientific Reports. 12(1). 3696–3696. 6 indexed citations
7.
Wolf, Stefan, et al.. (2019). Increased Reactive Oxygen Species Generation Contributes to the Atherogenic Activity of the B2 Bradykinin Receptor. Frontiers in Medicine. 6. 32–32. 10 indexed citations
8.
Quitterer, Ursula, et al.. (2018). Beta-Arrestin1 Prevents Preeclampsia by Downregulation of Mechanosensitive AT1-B2 Receptor Heteromers. Cell. 176(1-2). 318–333.e19. 50 indexed citations
9.
Cléry, Antoine, Thibault J. M. Sohier, Thomas Welte, Andreas Langer, & Frédéric H.‐T. Allain. (2017). switchSENSE: A new technology to study protein-RNA interactions. Methods. 118-119. 137–145. 29 indexed citations
10.
Langer, Andreas, et al.. (2015). Innovations in European social services: context, conceptual approach, and findings of the INNOSERV project. Innovation The European Journal of Social Science Research. 28(1). 81–97. 6 indexed citations
11.
Langer, Andreas, et al.. (2015). Polymerase/DNA interactions and enzymatic activity: multi-parameter analysis with electro-switchable biosurfaces. Scientific Reports. 5(1). 12066–12066. 29 indexed citations
12.
Langer, Andreas, W. Kaiser, Jelena Knežević‐Vukčević, et al.. (2013). Protein Sizing and Conformation Analysis with an Electro-Switchable DNA Chip. Biophysical Journal. 104(2). 194a–194a. 1 indexed citations
13.
Langer, Andreas, W. Kaiser, Jelena Knežević‐Vukčević, et al.. (2013). Protein analysis by time-resolved measurements with an electro-switchable DNA chip. Nature Communications. 4(1). 2099–2099. 83 indexed citations
14.
Langer, Andreas, et al.. (2010). Angiotensin-converting Enzyme Inhibition Down-regulates the Pro-atherogenic Chemokine Receptor 9 (CCR9)-Chemokine Ligand 25 (CCL25) Axis. Journal of Biological Chemistry. 285(30). 23496–23505. 42 indexed citations
15.
AbdAlla, Said, Heinz Lother, Andreas Langer, et al.. (2008). Angiotensin II AT2 Receptor Oligomers Mediate G-protein Dysfunction in an Animal Model of Alzheimer Disease. Journal of Biological Chemistry. 284(10). 6554–6565. 74 indexed citations
16.
AbdAlla, Said, Heinz Lother, П. В. Сергеев, et al.. (2008). Dominant Negative AT2 Receptor Oligomers Induce G-protein Arrest and Symptoms of Neurodegeneration. Journal of Biological Chemistry. 284(10). 6566–6574. 38 indexed citations
17.
Langer, Andreas, et al.. (2005). Soziale Institutionen zwischen Markt und Moral. VS Verlag für Sozialwissenschaften eBooks. 4 indexed citations
18.
Caillé, Isabelle, Bernadette Allinquant, Edmond Dupont, et al.. (2004). Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone. Development. 131(9). 2173–2181. 280 indexed citations
19.
AbdAlla, Said, Heinz Lother, Andreas Langer, Yasser el Faramawy, & Ursula Quitterer. (2004). Factor XIIIA Transglutaminase Crosslinks AT1 Receptor Dimers of Monocytes at the Onset of Atherosclerosis. Cell. 119(3). 343–354. 167 indexed citations
20.
Langer, Andreas, et al.. (2003). Ethische Implikationen der Ökonomisierung in der Medizin. Zeitschrift für Evangelische Ethik. 47(1). 21–32. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026